Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spherule-derived Coccidioidin Skin Test Safety and Efficacy
NCT00690092Phase 3Completed
- Sponsor
- Nielsen BioSciences, Inc.
- Start
- May 2005
- Primary completion
- Sep 2007
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
Phase 3, open-label trial of Coccidioides immitis spherule in coccidioidomycosis (3 arms), sponsored by Nielsen BioSciences, Inc. Primary endpoint: Delayed-Type Hypersensitivity Response at 48 hours. Started May 2005; status: completed.
02
Drugs
Coccidioides immitis spherule
03
Conditions
coccidioidomycosis
Beyond the preview
Go deeper on NCT00690092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00690092.